問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberIM0271015
NCT Number(ClinicalTrials.gov Identfier)-
Active

2023-10-16 - 2027-09-09

Phase III

Recruiting9

ICD-10J84.10

Pulmonary fibrosis, unspecified

ICD-10J84.112

Idiopathic pulmonary fibrosis

ICD-10J84.17

Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere

ICD-10J84.89

Other specified interstitial pulmonary diseases

ICD-9515

Postinflammatory pulmonary fibrosis

-

  • Trial Applicant

    BRISTOL-MYERS SQUIBB (TAIWAN) LTD.

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/17

Investigators and Locations

Principal Investigator Chau-Chyun Sheu Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chung-Yu Chen

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Ming -Cheng Chan Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chung-Yu Chen Division of General Internal Medicine

Co-Principal Investigator

  • 陳彥甫 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 黃國棟 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chih-Yen Tu Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator 林慶雄 Division of General Internal Medicine

Co-Principal Investigator

  • 林明泰 Division of General Internal Medicine
  • 施穎銘 Division of General Internal Medicine
  • 葉金水 Division of General Internal Medicine
  • 林俊維 Division of General Internal Medicine
  • 紀炳銓 Division of General Internal Medicine
  • 詹博強 Division of General Internal Medicine
  • 黃國揚 Division of General Internal Medicine
  • 林聖皓 Division of General Internal Medicine
  • 陳正雄 Division of General Internal Medicine
  • 蔡偉宏 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator HAO-CHIEN WANG

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    30 participants

  • Global

    1092 participants